Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
COSMOS Pharmaceutical Corporation ( (JP:3349) ) has issued an update.
COSMOS Pharmaceutical Corporation has announced changes in its board of directors, with nominations for new director roles to be confirmed at the upcoming Annual General Meeting. These changes are part of the company’s ongoing efforts to strengthen its leadership and enhance its strategic direction.
The most recent analyst rating on (JP:3349) stock is a Buy with a Yen9700.00 price target. To see the full list of analyst forecasts on COSMOS Pharmaceutical Corporation stock, see the JP:3349 Stock Forecast page.
More about COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange Prime Market under the securities code 3349.
Average Trading Volume: 368,005
Technical Sentiment Signal: Buy
Current Market Cap: Yen745.4B
See more data about 3349 stock on TipRanks’ Stock Analysis page.